Placebo News and Research RSS Feed - Placebo News and Research

Hormone can boost activity in brain regions linked to sexual arousal and love

Hormone can boost activity in brain regions linked to sexual arousal and love

The hormone kisspeptin can enhance activity in brain regions associated with sexual arousal and romantic love, according to new research. [More]
FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. [More]
Curcumin not likely to have therapeutic benefit, report reveals

Curcumin not likely to have therapeutic benefit, report reveals

Curcumin, a compound in turmeric, continues to be hailed as a natural treatment for a wide range of health conditions, including cancer and Alzheimer's disease [More]
Stress hormone has major effect on perception and perceptual learning

Stress hormone has major effect on perception and perceptual learning

Stress is part of our everyday lives - while some thrive on it, it makes others sick. But what does stress do to our senses? When we train them, we can sharpen our senses thereby improve our perceptual performance. [More]
Monthly high dose of vitamin D lowers respiratory infections in older adults

Monthly high dose of vitamin D lowers respiratory infections in older adults

In people over the age of 65, acute respiratory infections--such as the common cold, influenza, or pneumonia--can lead to potentially life-threatening complications. [More]
Researchers find promising results for treating depression with video game interface

Researchers find promising results for treating depression with video game interface

Researchers have found promising results for treating depression with a video game interface that targets underlying cognitive issues associated with depression rather than just managing the symptoms. [More]
Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease. [More]
Novel investigational drug may help restore cardiac function after heart failure

Novel investigational drug may help restore cardiac function after heart failure

Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure, according to a first-in-man study published today in JACC: Basic to Translational Science. [More]
MDA celebrates FDA approval of new spinal muscular atrophy drug

MDA celebrates FDA approval of new spinal muscular atrophy drug

The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants. [More]
Shortened antimicrobial treatment inferior to standard regimen for middle ear infections, study finds

Shortened antimicrobial treatment inferior to standard regimen for middle ear infections, study finds

A five-day antimicrobial treatment regimen for middle ear infections in young children is inferior to the standard 10-day regimen, according to newly published research in The New England Journal of Medicine. [More]
Researchers find effective cure for social anxiety disorders

Researchers find effective cure for social anxiety disorders

Social phobia is the most common anxiety disorder of our time. But the current treatment regimen for patients with this diagnosis has not proven very effective. Now a team of Norwegian and British researchers believe they have found a cure for social anxiety disorders. [More]
First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. [More]
Antibiotic gel shows promise in preventing onset of Lyme borreliosis following tick bite

Antibiotic gel shows promise in preventing onset of Lyme borreliosis following tick bite

An antibiotic gel based on azithromycin, an antibiotic with antibacterial properties, helps to prevent the onset of Lyme borreliosis following a tick bite. [More]
New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

New SWOG review shows vitamin E and selenium do not prevent colorectal adenomas

Eight years ago, results from a landmark cancer prevention trial run by SWOG showed that a daily dose of vitamin E and selenium did not prevent prostate cancer. [More]
Landmark clinical trial to test third investigational drug for Alzheimer's disease

Landmark clinical trial to test third investigational drug for Alzheimer's disease

An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease. [More]
Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore. [More]
Novel approach shows promise for treating co-occurring PTSD and SUD

Novel approach shows promise for treating co-occurring PTSD and SUD

N-acetylcysteine, when combined with group cognitive behavioral therapy, reduced symptoms of posttraumatic stress disorder (PTSD), cravings, and depression significantly more than CBT alone in veterans with co-occurring PTSD and substance use disorder, a particularly difficult-to-treat population, according to the findings of a randomized controlled pilot trial conducted by researchers at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center. [More]
Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

An over-the-counter antioxidant known as N-acetylcysteine (NAC) is showing early promise at promoting abstinence from or reduced use of alcohol in marijuana-dependent adolescents, report researchers at the Medical University of South Carolina (MUSC) in the December 2016 Addictive Behaviors. [More]
FDA approves new treatment option for patients dealing with mild to moderate eczema

FDA approves new treatment option for patients dealing with mild to moderate eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older. [More]
Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Stroke is the epidemic disease of the twenty-first century and the second most frequent cause of death in 2011, accounting for 11% of all deaths worldwide. Stroke is also the second most important cause of permanent disability and... [More]
Advertisement
Advertisement